Page last updated: 2024-11-11

isosalipurposide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isosalipurposide: petal pigment in flowers of Dianthus caryophyllus; RN given refers to (E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phlorizin chalcone : A monosaccharide derivative that is trans-chalcone substituted by hydroxy groups at positions 4, 4' and 6 and a beta-D-glucopyranosyloxy group at position 2' respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
DianthusgenusA plant genus of the family CARYOPHYLLACEAE. Members contain dianthins, which are ribosome inactivating proteins.[MeSH]CaryophyllaceaeA plant family of the order Caryophyllales, subclass Caryophyllidae, class Magnoliopsida. The species are diverse in appearance and habitat; most have swollen leaf and stem joints.[MeSH]

Cross-References

ID SourceID
PubMed CID5318659
CHEMBL ID2430461
CHEBI ID80486
MeSH IDM0088916

Synonyms (13)

Synonym
isosalipurposide
4547-85-7
chalcone 2'-o-glucoside
phlorizin chalcone
iso-salipurposide
(e)-1-[2,4-dihydroxy-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
chebi:80486 ,
CHEMBL2430461
2-propen-1-one, 1-(2-(beta-d-glucopyranosyloxy)-4,6-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (e)-
3,5-dihydroxy-2-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]phenyl beta-d-glucopyranoside
Q27149537
DTXSID801316840
AKOS040752128
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
resorcinolsAny benzenediol in which the two hydroxy groups are meta to one another.
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1235313Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as zone of inhibition at 3030 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1235316Antimicrobial activity against Streptococcus pyogenes 345/1 assessed as zone of inhibition at 3030 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1235312Antimicrobial activity against Escherichia coli ATCC 25922 assessed as zone of inhibition at 3030 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1235314Antimicrobial activity against methicillin-resistant Staphylococcus aureus 344/2-32 assessed as zone of inhibition at 3030 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1235317Antimicrobial activity against Candida albicans ATCC 10231 assessed as zone of inhibition at 3030 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
AID1235315Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as zone of inhibition at 3030 uM incubated overnight at 37 degC2015Journal of natural products, Jul-24, Volume: 78, Issue:7
Phytochemical Investigation of the Constituents Derived from the Australian Plant Macropidia fuliginosa.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]